CLBT logo

Cellebrite DI Ltd. (CLBT)

$10.65

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CLBT

Market cap

$2.68B

EPS

0.31

P/E ratio

--

Price to sales

5.95

Dividend yield

--

Beta

1.053197

Price on CLBT

Previous close

$11.12

Today's open

$11.04

Day's range

$10.43 - $11.07

52 week range

$9.58 - $19.39

Profile about CLBT

CEO

Shiven Ramji

Employees

1285

Headquarters

Petah Tikva,

Exchange

Nasdaq Global Select

Shares outstanding

251341060

Issue type

Common Stock

CLBT industries and sectors

Technology

Software & IT Services

News on CLBT

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cellebrite DI (CLBT)

Cellebrite DI (NASDAQ: CLBT) shares swung from an early earnings-day gain to a loss of about 14% on November 12, 2026, as the Company again lowered its full-year revenue guidance. Shareholders who took losses in that reversal may have legal rights. Cellebrite DI (NASDAQ: CLBT) shares swung from an early earnings-day gain to a loss of about 14% on November 12, 2026, as the Company again lowered its full-year revenue guidance. Shareholders who took losses in that reversal may have legal rights.

news source

GlobeNewsWire • 16 hours ago

news preview

Cellebrite DI: Continuous Innovation Including AI Can Drive Growth

Cellebrite DI combines double-digit growth and an attractive valuation, positioning the stock for a potential reversal of its multiyear downtrend. Q3 revenue rose 18% to $149 million and ARR increased 20% to $528.5 million, supported by federal and international demand. CLBT raised 2026 adjusted EBITDA guidance to $163 million–$166 million.

news source

Seeking Alpha • Nov 16, 2026

news preview

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

Cellebrite DI reported third-quarter results above key estimates on November 12, 2026, yet its shares traded down about 14% after the same report trimmed full-year revenue guidance again. Investors who lost money in the reversal may have legal rights.

news source

PRNewsWire • Nov 13, 2026

news preview

Cellebrite DI Q3 Earnings Call Highlights

Cellebrite DI NASDAQ: CLBT reported third-quarter revenue and annual recurring revenue growth of 18% and 20%, respectively, as international sales and improving U.S. federal demand helped the digital forensics company exceed its guidance.

news source

MarketBeat • Nov 12, 2026

news preview

Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript

Cellebrite DI Ltd. ( CLBT ) Q3 2026 Earnings Call November 12, 2026 8:30 AM EST Company Participants Andrew Kramer - VP of Investor Relations & Treasury Shiven Ramji - CEO & Director David Barter - Chief Financial Officer Marcus Jewell - Global Chief Revenue Officer Conference Call Participants Shaul Eyal - TD Cowen, Research Division Bhavin Shah - Deutsche Bank AG, Research Division Eric Martinuzzi - Lake Street Capital Markets, LLC, Research Division Jeff Van Rhee - Craig-Hallum Capital Group LLC, Research Division Brian Essex - JPMorgan Chase & Co, Research Division Rudy Kessinger - D.A.

news source

Seeking Alpha • Nov 12, 2026

news preview

Cellebrite Reports Third-Quarter 2026 Results

Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2026 /PRNewswire/ -- Cellebrite DI Ltd.

news source

PRNewsWire • Nov 12, 2026

news preview

Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate.

news source

Zacks Investment Research • Nov 12, 2026

news preview

Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026

TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 9, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its third-quarter 2026 financial results before the U.S. markets open on Thursday, November 12, 2026, which is unchanged from its October 20, 2026 announcement.

news source

PRNewsWire • Nov 9, 2026

news preview

Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development

Former Okta and SAP strategy leader brings AI, platform and M&A expertise to accelerate Cellebrite's growth TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 5, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the appointment of Rogerio Rizzi as executive vice president of Corporate Strategy and Development.

news source

PRNewsWire • Nov 5, 2026

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. - CLBT

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

news source

PRNewsWire • Oct 22, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Cellebrite DI Ltd.

Open an M1 investment account to buy and sell Cellebrite DI Ltd. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CLBT on M1